F770 in Maine. Pick another state for the same tag.
Against expectation — 2024
Maine cites F770 less often than its own record predicts
Versus expected share0.62×
0.62 times the national share — cited less often here than elsewhere.
Share of Maine citations0.13%
Of every deficiency written in Maine in 2024, this is the portion that was F770.
Maine0.13%
National0.21%
Share of all citations that were F770.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Maine surveyors wrote
F770 findings written in Maine, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJune 2, 2026
Based on record reviews and interviews, the facility failed to follow up on laboratory orders when there were no results for a lab ordered for 1 of 3 residents whose record was reviewed for thyroid treatment (Resident #3).Findings:1. Resident #3's medical record indicated an order for Comprehensive Metabolic Panel (CMP), Complete Blood Count with Diff (CBC with diff), and Thyroid Stimulating Hormone, (TSH), dated 3/10/26. The lab results included CMP and CBC with diff, however, lacked evidence of TSH.2. Resident #3's medical record indicated an order for Comprehensive Metabolic Panel (CMP), Complete Blood Count without Diff (CBC w/o diff),and Thyroid Stimulating Hormone, (TSH), dated 4/5/26. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction